Health TrialsbyHealthPanel

PENG vs Deep Iliacus Plane Block in Intertrochanteric Femur Fractures

ConditionsPostoperative AnalgesiaHip Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorErzincan Binali Yildirim Universitesi

About this trial

Intertrochanteric femur fractures are common in elderly patients and are associated with significant pain. Providing effective analgesia is clinically important both during positioning for spinal anesthesia and in the postoperative period in this patient population.

The Pericapsular Nerve Group (PENG) block is a regional anesthesia technique that targets the articular branches of the hip capsule and may provide effective analgesia with motor-sparing potential. The Deep Iliacus Plane Block (DIPB) is a newer approach that may spread to both the articular branches and the lateral femoral cutaneous nerve.

Although both blocks are used in patients with intertrochanteric fractures, there is a lack of sufficient randomized controlled data comparing their effectiveness for pain during positioning for spinal anesthesia and for postoperative analgesia. Therefore, it is important to determine which technique provides greater clinical benefit.

The aim of this study is to compare the analgesic efficacy of the PENG block and the Deep Iliacus Plane Block during positioning for spinal anesthesia and in the postoperative period in patients undergoing surgery for intertrochanteric femur fractures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients scheduled for elective surgery for intertrochanteric femur fractures

Patients with ASA physical status I, II, or III

Patients aged between 30 and 85 years

Disqualifiers

Patients with ASA physical status IV or higher

Patients undergoing emergency surgery

Patients who refuse to participate or withdraw consent during the study

Patients with cognitive dysfunction such as Alzheimer's disease, dementia, or delirium

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intravenous Analgesia

    Drug

    Standard preoperative intravenous analgesia according to institutional protocol.

  • Pericapsular nerve group (PENG) block

    Procedure/Surgery

    Ultrasound-guided PENG block with injection of 30 mL of 0.25% bupivacaine.

  • Deep Iliacus Plane Block (DIPB)

    Procedure/Surgery

    Ultrasound-guided Deep Iliacus Plane Block with injection of 30 mL of 0.25% bupivacaine.

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: Control Group (Group C)Active comparator 1 intervention
Group B: PENG Block Group (Group P)Experimental treatment 1 intervention
Group C: Deep Iliacus Plane Block Group (Group D)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pain during positioning for spinal anesthesia

Pain intensity during positioning for spinal anesthesia assessed using the Numerical Rating Scale (NRS, 0-10).

Time frame
During positioning (approximately 30 minutes after block)

Secondary outcomes

1

Postoperative pain scores

Postoperative pain assessed using the Numerical Rating Scale

Time frame
3, 6, 12, and 24 hours postoperatively
2

Total analgesic consumption

Total amount of rescue and routine analgesics used within 24 hours.

Time frame
First 24 postoperative hours
3

Need for rescue analgesia

Proportion of patients requiring rescue analgesia (NRS ≥4).

Time frame
First 24 postoperative hours
4

Motor block assessment

Motor block evaluated via isometric quadriceps contraction test.

Time frame
30 minutes after block

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Erzincan Binali Yildirim Universitesi

Lead sponsor

Source ClinicalTrials.gov
Apply now